Felix Woodhead is a consultant respiratory physician and clinical lead of the ILD service at Glenfield Hospital, Leicester. He studied for his PhD under Prof Athol Wells at the Royal Brompton before his first consultant job at Coventry where he established an ILD service from scratch. In 2014 he moved to Glenfield.
Dr Woodhead has a particular interest in ILD occurring in the context of rheumatological disease. He is the UK chief investigator of the international TRAIL1 placebo-controlled study of pirfenidone in ILD associated with Rheumatoid Arthritis. He is the current chair of the British Thoracic Society ILD special advisory group.